COLLEEN FORNEAR: Open Payments
NPI 1962120774 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$527 in 29 payments from 6 companies in 2025. Trend: 2023 $19 · 2024 $194 · 2025 $527
Food & beverage: $527
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $176 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $141 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $89 |
| Teva Pharmaceuticals USA, Inc. | 3 | $78 |
| Lundbeck LLC | 1 | $23 |
| Collegium Pharmaceutical, Inc. | 1 | $20 |
Products named: VRAYLAR, CAPLYTA, TRINTELLIX, AUSTEDO XR, REXULTI, Jornay PM.
Industry payments across AZ — which companies pay providers there.
